Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/6798
Title: An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Authors: Helen L., Young
Emily J., Rowling
Mattia, Bugatti
Giurisato, Emanuele 
Nadia, Luheshi
Imanol, Arozarena
Juan‑carlos, Acosta
Jivko, Kamarashev
Dennie T., Frederick
Zachary A., Cooper
Alexandre, Reuben
Jesus, Gil
Keith T., Flaherty
Jennifer A., Wargo
William, Vermi
Michael P., Smith
Claudia, Wellbrock
Adam, Hurlstone
Keywords: METASTATIC MELANOMA, CXCR2 ANTAGONIST, MALIGNANT-MELANOMA, TUMOR-GROWTH, RHEUMATOID-ARTHRITIS, ACQUIRED-RESISTANCE, RAF INHIBITION, TNF-ALPHA, IN-VITRO, BRAF
Issue Date: 2017
Project: None 
Journal: THE JOURNAL OF EXPERIMENTAL MEDICINE
Description: 
101058
URI: http://hdl.handle.net/20.500.12779/6798
ISSN: 1540-9538
DOI: 10.1084/jem.20160855
Appears in Collections:Publications

Show full item record

Page view(s)

92
Last Week
0
Last month
8
checked on May 8, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.